Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any classic complement early component deficiency in which the cause of the disease is a mutation in the C7 gene.
Features include always present findings: Recurrent Neisserial infections and Decreased circulating complement C7 concentration. 3 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 1 | Recurrent Neisserial infections |
C7 encodes complement C7 (843 aa). Component of the membrane attack complex (MAC), a multiprotein complex activated by the complement cascade, which inserts into a target cell membrane and forms a pore, leading to target cell membrane rupture and cell lysis. Highest expression in Ovary (1,371 TPM) and Fallopian Tube (704.6 TPM).
Complement component 7 deficiency is associated with mutations in the C7 gene on chromosome 5.
The C7 protein participates in C5b:C6:C7 translocates to the plasma membrane and Formation of soluble VTN:C5b-C9 pathways.
C7 is classified as a druggable target (Druggable Genome category) with score 0.6.
Genetic testing for C7 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 2 always present features.
No clinical trials have been registered for complement component 7 deficiency.
3 publications have been identified in PubMed for complement component 7 deficiency. Research spans Basic Science / Preclinical (67%) and Review / Meta-Analysis (33%).
Smith-Jackson K (2025). [PMID: 39848404](https://pubmed.ncbi.nlm.nih.gov/39848404/). *Kidney Int*. [Basic Science / Preclinical]
Zelek WM (2024). [PMID: 38485063](https://pubmed.ncbi.nlm.nih.gov/38485063/). *Brain Behav Immun*. [Basic Science / Preclinical]
Oprea Y (2024). [PMID: 38951460](https://pubmed.ncbi.nlm.nih.gov/38951460/). *Am J Clin Dermatol*. [Review / Meta-Analysis]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 1:59 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Common questions about complement component 7 deficiency